[tilialucida/Adobe Stock]
The pharma and biotech sectors continue to face rapid change. On one hand, top pharma employers have continued to face talent shortages as demand increases for experienced workers. But on the other, the pharma sector has not been immune to layoffs. One factor driving the trend is the increased clip of mergers and acquisitions (M&A) activity, which can result in restructuring but also new job opportunities as companies sharpen their focus on pipeline gaps and developing novel therapeutics. The pharma industry is in the process of reassessing long-term strategies in domains such as sourcing, manufacturing and supply chain management, according to McKinsey. These trends have gained steam in recent years as a result of factors such as inflation, the ongoing pandemic, the shifting geopolitical climate and the development of novel therapeutic methods and new ways of working. The rapid evolution …